Von Graefe's sign

From WikiMD's WELLNESSPEDIA


Von Graefe's sign
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Delayed movement of the upper eyelid when the eye moves downward
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes Graves' disease, thyroid eye disease
Risks N/A
Diagnosis Clinical examination
Differential diagnosis Lid lag, ptosis
Prevention N/A
Treatment Treatment of underlying condition (antithyroid drugs, radioiodine therapy, surgery)
Medication N/A
Prognosis Depends on underlying cause
Frequency Common in patients with Graves' disease
Deaths N/A


Von Graefe's sign is a clinical sign in ophthalmology that is often associated with Graves' disease, a type of hyperthyroidism. It is named after the German ophthalmologist Albrecht von Graefe who first described it.

Description[edit]

Von Graefe's sign is characterized by a lag in the downward movement of the upper eyelid (known as eyelid lag) during downward gaze. This results in an abnormal widening of the palpebral fissure (the space between the upper and lower eyelids) during downward gaze. It is one of the most common signs of Graves' disease, but it can also be seen in other conditions that affect the extraocular muscles.

Pathophysiology[edit]

The pathophysiology of Von Graefe's sign is not completely understood. It is believed to be due to an imbalance in the function of the extraocular muscles, specifically the levator palpebrae superioris muscle and the superior rectus muscle. In Graves' disease, these muscles are often affected by the autoimmune process, leading to inflammation and fibrosis. This results in a restriction of the normal movement of the upper eyelid.

Clinical significance[edit]

Von Graefe's sign is a useful clinical sign in the diagnosis of Graves' disease. It is one of the earliest signs of the disease and is often present before other symptoms such as exophthalmos (protrusion of the eyes) and goiter (enlargement of the thyroid gland). However, it is not specific for Graves' disease and can be seen in other conditions that affect the extraocular muscles.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.